Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Drug selection for malignant melanoma using biomarkers generated by weighted gene co-expression network analysis (WGCNA)
Download
index.pdf
Date
2017
Author
Alpsoy, Semih
Metadata
Show full item record
Item Usage Stats
216
views
102
downloads
Cite This
Chemotherapy is one of the widely applied treatment choices for cancer patients; however, it might not be effective in the majority of patients due to the inability of foreseeing which patients respond to which chemotherapeutic agents. In order to ascertain appropriate chemotherapy for patients, thus, drug biomarkers predicting the response of the patients to chemotherapy should be discovered and translated into clinical practice to decide the ideal chemotherapeutic agents in a patient-centric manner. In this way, it might be possible to tackle cancer disease more effectively, extend the life expectancy of the patients, and economize health expenditures substantially. In addition, discovering drug biomarkers might pave the way for drug target identification, drug discovery process, and eludicating drug mechanism of actions. Because of all these reasons, a systems biology based network approach known as Weighted Gene Co-Expression Network Analysis (WGCNA) is utilized in this study to discover candidate biomarkers for anti-cancer drugs profiled in two large pharmacogenomics studies, the Cancer Cell Line Encyclopedia (CCLE) and the Cancer Genome Project (CGP). In the study, malignant melanoma is selected as a model disease, and only the common anti-cancer drugs between the two pharmacogenomics studies screened against human malignant melanoma cell lines are considered. Both gene expression and drug sensitivity data available in the studies are integrated to identify candidate biomarkers for these common anti-cancer drugs. Next, support vector machine regression (SVR) machine learning algorithm is employed to assess the predictive ability of the identified candidate biomarkers both individually and in combinations. For that purpose, the CCLE expression data of the candidate biomarkers and the CCLE drug sensitivity data are trained in the first step. Predictive ability of these candidate biomarkers is tested in an independent CGP dataset later on. Thereby, in-silico validation of several candidate biomarkers could be accomplished. In conclusion, this thesis shows that the WGCNA methodology is a powerful approach for identifying gene expression-based candidate drug biomarkers for malignant melanoma. The thesis also shows that proper combinations of the candidate biomarkers generated by the WGCNA methodology improve anti-cancer drug sensitivity prediction significantly, and only a few gene combinations are sufficient to predict anti-cancer drug sensitivity powerfully.
Subject Keywords
Melanoma.
,
Chemotherapy.
,
Drug utilization.
,
Gene expression.
,
Biochemical markers.
,
Personalized medicine.
URI
http://etd.lib.metu.edu.tr/upload/12620703/index.pdf
https://hdl.handle.net/11511/26235
Collections
Graduate School of Informatics, Thesis
Suggestions
OpenMETU
Core
Targeted co-delivery of doxorubicin and TPGS to breast cancer cells by PLGA coated magnetic nanoparticles
Metin, Esra; Gündüz, Ufuk; Mutlu, Pelin; Department of Biotechnology (2017)
Although conventional chemotherapy is the most common method for cancer treatment, it has several side effects such as neuropathy, alopecia and cardiotoxicity. Since the drugs are given to body systemically, normal cells also effect as cancer cells. However, in recent years, targeted drug delivery has been developed to overcome these drawbacks.The targeting strategy can be changed depending on carrier types, but magnetic nanoparticles are commonly preferred due to their easy targetable features by using ext...
The role of 15-LOX-1 in resistance to chemotherapeutics
Kazan, Hasan Hüseyin; Gündüz, Ufuk; Department of Biology (2020)
Chemotherapy is one of the best options to treat cancer. However, drug resistance can limit the efficacy of chemotherapeutics. There have been several reasons for the cancer drug resistance including the export of the drug from cells, inactivation of drugs by enzymatic processes, mutations that limit the binding of the drugs to the target proteins, resistance to cell death mechanism by cellular manipulations and reorganization of the cell membrane. 15-Lipoxygenase-1 (15-LOX-1) is a member of the lipoxygenas...
Preparation and evaluation of polymer based microcarriers for hydrophobic anti-cancer drugs
Demetçi, Demet; Gündüz, Ufuk; Department of Biotechnology (2007)
Chemotherapy is one of the most important treatments for cancer. However, systemic toxicity, drug resistance and unstable kinetics of the drug in the blood are serious problems of chemotherapy. The use of biodegradable polymers for controlled release of anticancer drugs has gained popularity in recent years. Controlled release of drugs from polymeric carriers has some advantages such as improvement in the efficiency of treatment, reduction in systemic toxicity and prevention of the drug resistance that is d...
Vimentin silencing effect on invasive and migration characteristics of doxorubicin resistant MCF-7 cells
Tezcan, Okan; Gündüz, Ufuk (2014-04-01)
Chemotherapy is one of the well-known treatments in cancer therapy. The effectiveness of chemotherapy is limited by several factors one of which is the emergence of multidrug resistance (MDR). One of the major mechanisms of MDR is the activity of several ATP binding cassette (ABC) transporters that pump drugs out of the cells. Doxorubicin intercalates and inhibits DNA replication; it is a powerful chemotherapeutic agent. However, it causes development of MDR in tumor cells. Vimentin is a type III intermedia...
Metastatic behaviour of doxorubicin resistant MCF-7 breast cancer cells after Vimentin silencing
Tezcan, Okan; Gündüz, Ufuk; Department of Biology (2013)
Chemotherapy is one of the common treatments in cancer therapy. The effectiveness of chemotherapy is limited by several factors one of which is the emergence of multidrug resistance (MDR). MDR is caused by the activity of diverse ATP binding cassette (ABC) transporters that pump drugs out of the cells. There are several drugs which have been used in treatment of cancer. One of them is doxorubicin that intercalates and inhibits DNA replication. However, doxorubicin has been found to cause development of MDR ...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
S. Alpsoy, “Drug selection for malignant melanoma using biomarkers generated by weighted gene co-expression network analysis (WGCNA),” M.S. - Master of Science, Middle East Technical University, 2017.